![](https://ml-eu.globenewswire.com/media/d366696e-a2bc-4487-8d97-07dbec10d458/small/tx-png.png)
Release Therapeutics Announces New CEO to Drive Best-in-Class CNS Innovation
GENEVA, June 27, 2024 (GLOBE NEWSWIRE) -- Release Therapeutics (‘Release Tx’ or ‘the Company’), a privately-held, Swiss BioMedTech company, announced today the appointment of Thomas Mehrling, MD, PhD, as CEO. The appointment follows the recent strategic …